Revelation Biosciences Stock Market Value
| REVBW Stock | USD 0.01 0.0001 0.81% |
| Symbol | Revelation |
Revelation Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.77) | Return On Assets (0.51) | Return On Equity (2.70) |
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Revelation Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Revelation Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Revelation Biosciences.
| 05/09/2023 |
| 11/29/2024 |
If you would invest 0.00 in Revelation Biosciences on May 9, 2023 and sell it all today you would earn a total of 0.00 from holding Revelation Biosciences or generate 0.0% return on investment in Revelation Biosciences over 570 days. Revelation Biosciences is related to or competes with Cue Biopharma, Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, Enliven Therapeutics, and Molecular Partners. Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-base... More
Revelation Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Revelation Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Revelation Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.46 | |||
| Information Ratio | 0.0216 | |||
| Maximum Drawdown | 43.09 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 17.04 |
Revelation Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Revelation Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Revelation Biosciences' standard deviation. In reality, there are many statistical measures that can use Revelation Biosciences historical prices to predict the future Revelation Biosciences' volatility.| Risk Adjusted Performance | 0.0363 | |||
| Jensen Alpha | 0.2925 | |||
| Total Risk Alpha | (1.06) | |||
| Sortino Ratio | 0.0189 | |||
| Treynor Ratio | 1.73 |
Revelation Biosciences Backtested Returns
At this stage we consider Revelation Stock to be out of control. Revelation Biosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.0218, which implies the firm had a 0.0218% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Revelation Biosciences, which you can use to evaluate the volatility of the company. Please check Revelation Biosciences' Semi Deviation of 7.89, risk adjusted performance of 0.0363, and Coefficient Of Variation of 2828.7 to confirm if the risk estimate we provide is consistent with the expected return of 0.19%. Revelation Biosciences has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.18, which implies not very significant fluctuations relative to the market. As returns on the market increase, Revelation Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Revelation Biosciences is expected to be smaller as well. Revelation Biosciences right now holds a risk of 8.76%. Please check Revelation Biosciences treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day typical price , to decide if Revelation Biosciences will be following its historical price patterns.
Auto-correlation | 0.36 |
Below average predictability
Revelation Biosciences has below average predictability. Overlapping area represents the amount of predictability between Revelation Biosciences time series from 9th of May 2023 to 18th of February 2024 and 18th of February 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Revelation Biosciences price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Revelation Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Revelation Biosciences lagged returns against current returns
Autocorrelation, which is Revelation Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Revelation Biosciences' stock expected returns. We can calculate the autocorrelation of Revelation Biosciences returns to help us make a trade decision. For example, suppose you find that Revelation Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Revelation Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Revelation Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Revelation Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Revelation Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Revelation Biosciences Lagged Returns
When evaluating Revelation Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Revelation Biosciences stock have on its future price. Revelation Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Revelation Biosciences autocorrelation shows the relationship between Revelation Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Revelation Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.